{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:39:26Z","timestamp":1777545566149,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ecl.2022.04.007","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T21:36:34Z","timestamp":1665696994000},"page":"837-852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Quality of Life in Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"51","author":[{"given":"Cristiana","family":"Cipriani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisella","family":"Cianferotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ecl.2022.04.007_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.beem.2018.06.006","article-title":"Non classical complications of primary hyperparathyroidism","volume":"32","author":"Chiodini","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.007_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0002-9343(87)90068-4","article-title":"Acute primary hyperparathyroidism","volume":"82","author":"Fitzpatrick","year":"1987","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.ecl.2022.04.007_bib3","doi-asserted-by":"crossref","first-page":"e0127574","DOI":"10.1371\/journal.pone.0127574","article-title":"Parathyroid hormone, cognitive function and dementia: a systematic review","volume":"10","author":"Lourida","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.007_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/14737167.2014.873702","article-title":"Quality of life in patients with primary hyperparathyroidism","volume":"14","author":"Cipriani","year":"2014","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.007_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/cen.14045","article-title":"Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism","volume":"91","author":"Kearns","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.007_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/2013.jamasurg.316","article-title":"Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study","volume":"148","author":"Weber","year":"2013","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.007_bib7","first-page":"9","article-title":"Neuropsychological changes and health-related quality of life in patients with asymptomatic primary hyperparathyroidism","volume":"21","author":"Y\u0131lmaz","year":"2017","journal-title":"Asemptomatik primer hiperparatiroidizmi olan hastalarda n\u00f6ropsiklojik de\u011fi\u015fiklikler ve ya\u015fam kalitesi"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.007_bib8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/lary.26617","article-title":"Early neurocognitive improvements following parathyroidectomy for primary hyperparathyroidism","volume":"128","author":"Shah-Becker","year":"2018","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.007_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S0004-27302013000200007","article-title":"Lower quality of life in longstanding mild primary hyperparathyroidism","volume":"57","author":"Veras","year":"2013","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.007_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/bjs.10739","article-title":"Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism","volume":"105","author":"Bannani","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ecl.2022.04.007_bib11","doi-asserted-by":"crossref","first-page":"115583","DOI":"10.1016\/j.bone.2020.115583","article-title":"Impaired physical function and evaluation of quality of life in normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"141","author":"Voss","year":"2020","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.ecl.2022.04.007_bib12","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2022.04.007_bib13","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2022.04.007_bib14","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.007_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.4199","article-title":"Effects of parathyroidectomy on quality of life: 10 years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-Study)","volume":"36","author":"Pretorius","year":"2021","journal-title":"J\u00a0Bone Miner Res"},{"issue":"4","key":"10.1016\/j.ecl.2022.04.007_bib16","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1210\/jc.2015-3094","article-title":"Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism","volume":"101","author":"Webb","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.007_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/EC-15-0053","article-title":"Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument","volume":"4","author":"Ryhanen","year":"2015","journal-title":"Endocr Connect"},{"issue":"6","key":"10.1016\/j.ecl.2022.04.007_bib18","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1210\/jc.2008-2574","article-title":"Neuropsychological features in primary hyperparathyroidism: a prospective study","volume":"94","author":"Walker","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.007_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SLA.0b013e3181f66720","article-title":"The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism","volume":"253","author":"Roman","year":"2011","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.ecl.2022.04.007_bib20","doi-asserted-by":"crossref","first-page":"E1737","DOI":"10.1210\/jc.2011-1486","article-title":"Depression in primary hyperparathyroidism: prevalence and benefit of surgery","volume":"96","author":"Espiritu","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.007_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.surg.2020.06.006","article-title":"Neuropsychologic changes in primary hyperparathyroidism after parathyroidectomy from a dual-institution prospective study","volume":"169","author":"Liu","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2022.04.007_bib22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00268-002-6623-y","article-title":"Patient-based Surgical Outcome Tool Demonstrating Alleviation of Symptoms following Parathyroidectomy in Patients with Primary Hyperparathyroidism","volume":"26","author":"Pasieka","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.ecl.2022.04.007_bib23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s00268-007-9006-6","article-title":"Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism","volume":"31","author":"Weber","year":"2007","journal-title":"World J Surg"},{"issue":"305","key":"10.1016\/j.ecl.2022.04.007_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","article-title":"Validating the SF-36 health survey questionnaire: new outcome measure for primary care","volume":"18","author":"Brazier","year":"1992","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.007_bib25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000508374","article-title":"Health-related quality of life in patients with multiple endocrine neoplasia type 1","volume":"111","author":"van Leeuwaarde","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.007_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12020-020-02384-4","article-title":"SF-12 or SF-36 in pituitary disease? Toward concise and comprehensive patient-reported outcomes measurements","volume":"70","author":"van der Meulen","year":"2020","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.ecl.2022.04.007_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.ecl.2022.04.007_bib28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00268-008-9509-9","article-title":"Pasieka\u2019s parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism","volume":"32","author":"Mihai","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/j.ecl.2022.04.007_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1477-7525-11-97","article-title":"Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism","volume":"11","author":"Webb","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ecl.2022.04.007_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/07853890109002086","article-title":"The 15D instrument of health-related quality of life: properties and applications","volume":"33","author":"Sintonen","year":"2001","journal-title":"Ann Med"},{"issue":"7","key":"10.1016\/j.ecl.2022.04.007_bib31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2017.16111226","article-title":"Psychiatric complications of primary hyperparathyroidism and mild hypercalcemia","volume":"17","author":"Parks","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.ecl.2022.04.007_bib32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40618-015-0423-3","article-title":"Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms","volume":"39","author":"Trombetti","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ecl.2022.04.007_bib33","first-page":"69","article-title":"Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the city of recife, Brazil","volume":"6","author":"Eufrazino","year":"2013","journal-title":"Clin Med Ins"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.007_bib34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40618-019-01128-0","article-title":"Cognition and cerebrovascular function in primary hyperparathyroidism before and after parathyroidectomy","volume":"43","author":"Liu","year":"2020","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"10.1016\/j.ecl.2022.04.007_bib35","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1007\/s00268-018-4575-0","article-title":"Changing profile of primary hyperparathyroidism over two and half decades: A Study in Tertiary Referral Center of North India","volume":"42","author":"Yadav","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.ecl.2022.04.007_bib36","doi-asserted-by":"crossref","first-page":"952426","DOI":"10.1155\/2012\/952426","article-title":"Primary hyperparathyroidism: 11-year experience in a single institute in Thailand","volume":"2012","author":"Prasarttong-Osoth","year":"2012","journal-title":"Int J Endocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2022.04.007_bib37","first-page":"745","article-title":"Three generational phenotypes of sporadic primary hyperparathyroidism: evolution defined by technology","volume":"7","author":"Cipriani","year":"2019"},{"issue":"8","key":"10.1016\/j.ecl.2022.04.007_bib38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S2213-8587(16)00076-0","article-title":"Explaining geographical variation in the presentation of primary hyperparathyroidism","volume":"4","author":"Minisola","year":"2016","journal-title":"Lancet Diab Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2022.04.007_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00268-013-2273-5","article-title":"Muscle function is impaired in patients with \"asymptomatic\" primary hyperparathyroidism","volume":"38","author":"Rolighed","year":"2014","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.007_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-14-0757","article-title":"Health-related quality of life after successful surgery for primary hyperparathyroidism:no additive effect from vitamin D supplementation: results of a double-blind randomized study","volume":"172","author":"A\u00b0 berg","year":"2015","journal-title":"Europ J Endocrinol"},{"key":"10.1016\/j.ecl.2022.04.007_bib41","doi-asserted-by":"crossref","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. Available at: https:\/\/publons.com\/publon\/10.1002\/jbmr.4677. Accessed August 19, 2022. DOI: https:\/\/doi.org\/10.1002\/jbmr.4677.","DOI":"10.1002\/jbmr.4677"},{"issue":"10","key":"10.1016\/j.ecl.2022.04.007_bib42","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.007_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. a Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2022.04.007_bib44","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.surg.2005.08.033","article-title":"Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism","volume":"138","author":"Roman","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2022.04.007_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijsu.2014.12.004","article-title":"The extent of improvement of health-related quality of life as assessed by the SF36 and Paseika scales after parathyroidectomy in patients with primary hyperparathyroidism--a systematic review and meta-analysis","volume":"13","author":"Brito","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.ecl.2022.04.007_bib46","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archsurg.137.9.1022","article-title":"Surgical treatment of hyperparathyroidism improves health-related quality of life","volume":"137","author":"Sheldon","year":"2002","journal-title":"Arch Surg"},{"key":"10.1016\/j.ecl.2022.04.007_bib47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1445-2197.2004.02907.x","article-title":"Pasieka Illness Questionnaire: its value in primary hyperparathyroidism","volume":"74","author":"Greutelaers","year":"2004","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ecl.2022.04.007_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.surg.2006.12.004","article-title":"Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up)","volume":"141","author":"Caillard","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2022.04.007_bib49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.surge.2009.10.005","article-title":"Health-related quality of life improvement following surgical treatment of primary hyperparathyroidism in a United Kingdom population","volume":"8","author":"Leong","year":"2010","journal-title":"Surgeon"},{"key":"10.1016\/j.ecl.2022.04.007_bib50","first-page":"96","article-title":"Salutary effect of parathyroidectomy on neuropsychiatric symptoms in patients with primary hyperparathyroidism: evaluation using PAS and SF-36v2 scoring systems","volume":"57","author":"Ramakant","year":"2011","journal-title":"J\u00a0Postgrad Med"},{"key":"10.1016\/j.ecl.2022.04.007_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.surg.2016.05.047","article-title":"Parathyroidectomy for primary hyperparathyroidism improves sleep quality: a prospective study","volume":"161","author":"La","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2022.04.007_bib52","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.eprac.2021.01.003","article-title":"Quality of life in patients with asymptomatic primary hyperparathyroidism after parathyroidectomy: a 3-year longitudinal study","volume":"27","author":"Tzikos","year":"2021","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ecl.2022.04.007_bib53","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.surg.2009.10.021","article-title":"The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study","volume":"146","author":"Pasieka","year":"2009","journal-title":"Surgery"},{"issue":"11","key":"10.1016\/j.ecl.2022.04.007_bib54","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-014-3731-5","article-title":"Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study","volume":"21","author":"Blanchard","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ecl.2022.04.007_bib55","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hed.24499","article-title":"Impact of parathyroidectomy for primary hyperparathyroidism on quality of life: a case-control study using Short Form Health Survey 36","volume":"38","author":"Dulfer","year":"2016","journal-title":"Head Neck"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2022.04.007_bib56","first-page":"E300","article-title":"Long-term prospective evaluation comparing robotic parathyroidectomy with minimally invasive open parathyroidectomy for primary hyperparathyroidism","volume":"38","author":"Tolley","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.ecl.2022.04.007_bib57","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.surg.2009.09.034","article-title":"Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with \"asymptomatic\" primary hyperparathyroidism","volume":"146","author":"Perrier","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2022.04.007_bib58","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/SLA.0b013e3181d76bb3","article-title":"Parathyroidectomy improves functional capacity in \"asymptomatic\" older patients with primary hyperparathyroidism: a randomized control trial","volume":"251","author":"Morris","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ecl.2022.04.007_bib59","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s40618-020-01447-7","article-title":"Efficacy of parathyroidectomy compared with active surveillance in patients with mild asymptomatic primary hyperparathyroidism: a systematic review and meta-analysis of randomized-controlled studies","volume":"44","author":"Anagnostis","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.ecl.2022.04.007_bib60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/cen.13865","article-title":"Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study","volume":"90","author":"Ejlsmark-Svensson","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2022.04.007_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.4225","article-title":"Quality of life in primary hyperparathyroidism revisited: keep calm and carry on?","volume":"36","author":"Walker","year":"2021","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2022.04.007_bib62","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1530\/EC-20-0221","article-title":"Cinacalcet and primary hyperparathyroidism: systematic review and meta regression","volume":"9","author":"Ng","year":"2020","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ecl.2022.04.007_bib63","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s42000-021-00292-4","article-title":"Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism","volume":"20","author":"Timmons","year":"2021","journal-title":"Hormones"},{"issue":"2","key":"10.1016\/j.ecl.2022.04.007_bib64","doi-asserted-by":"crossref","first-page":"zraa029","DOI":"10.1093\/bjsopen\/zraa029","article-title":"Prediction of cognitive response to surgery in elderly patients with primary hyperparathyroidism","volume":"5","author":"Koman","year":"2021","journal-title":"BJS Open"},{"key":"10.1016\/j.ecl.2022.04.007_bib65","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/bjs.11319","article-title":"Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy","volume":"106","author":"Koman","year":"2019","journal-title":"BJS"},{"issue":"12","key":"10.1016\/j.ecl.2022.04.007_bib66","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s00198-016-3715-3","article-title":"Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis","volume":"27","author":"Singh Ospina","year":"2016","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.ecl.2022.04.007_bib67","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40618-021-01710-5","article-title":"The impact of age on quality of life and frailty outcomes after parathyroidectomy in patients with primary hyperparathyroidism","volume":"45","author":"Papavramidis","year":"2021","journal-title":"J\u00a0Endocrinol Invest"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985292200038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985292200038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:47:24Z","timestamp":1760176044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985292200038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S088985292200038X"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2022.04.007","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life in Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2022.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}